Wolverine Asset Management’s Humacyte Inc Warrant HUMAW Stock Holding History
Bought
Maintained
Sold
Other funds holding HUMAW
SCM
TSS
CS
Wolverine Asset Management's HUMAW Position: Q2 2026 in Review
Wolverine Asset Management increased its Humacyte Inc Warrant (HUMAW) stake by 28% in Q2 2026, buying an estimated $681 and bringing the position to 48,429 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #1609.
Wolverine Asset Management first reported a position in HUMAW in Q4 2020 and has held it in 13 quarters since. The position peaked at $112K in Q2 2024. 8 funds tracked by Wall St. Rank hold HUMAW as of Q2 2026.
- Wolverine Asset Management held 48,429 shares of Humacyte Inc Warrant worth $465 as of Q2 2026.
- Wolverine Asset Management bought 10,454 Humacyte Inc Warrant shares in Q2 2026, an estimated $681.
- Humacyte Inc Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1609 holding.
- Wolverine Asset Management first reported a position in Humacyte Inc Warrant in Q4 2020 and has held it in 13 quarters since.
- Wolverine Asset Management's Humacyte Inc Warrant position peaked at $112K in Q2 2024.
- 8 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2026.
Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.